Start a New Search
SHOWING 2 RESULTS
a new diagnostic tool developed at UC Santa Cruz combines optofluidics and nanopore technology to test for SARS-CoV-2 and Zika virus.
University Research | Confronting COVID-19 | University of California Santa Cruza UCSC paper discusses the global biopharmaceutical industry's response to the COVID-19 pandemic and the issues of access to testing tools, vaccines, and other biomedical countermeasures.
University Research | Confronting COVID-19 | University of California Santa Cruz